Intensity Therapeutics Files 8-K on Financials
Ticker: INTS · Form: 8-K · Filed: May 13, 2025 · CIK: 1567264
| Field | Detail |
|---|---|
| Company | Intensity Therapeutics, Inc. (INTS) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: INTT
TL;DR
INTENSITY THERAPEUTICS (INTT) FILED AN 8-K ON 5/13/25 DETAILING FINANCIALS AND EXHIBITS.
AI Summary
Intensity Therapeutics, Inc. filed an 8-K on May 13, 2025, reporting on its Results of Operations and Financial Condition, as well as Financial Statements and Exhibits. The filing details the company's financial status and provides supporting documentation.
Why It Matters
This filing provides investors with crucial updates on Intensity Therapeutics' financial health and operational performance, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate operational or market risks.
Key Players & Entities
- INTENSITY THERAPEUTICS, INC. (company) — Registrant
- May 13, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- 1 Enterprise Drive, Suite 430 Shelton, CT 06484 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Intensity Therapeutics, Inc.'s Results of Operations and Financial Condition, and to provide Financial Statements and Exhibits.
On what date was this 8-K filed?
This 8-K was filed on May 13, 2025.
What is the company's state of incorporation?
The company's state of incorporation is Delaware.
What is the address of the company's principal executive offices?
The address of the company's principal executive offices is 1 Enterprise Drive, Suite 430, Shelton, CT 06484.
Does this filing indicate any specific operational changes or events?
This filing primarily concerns the company's financial condition and statements, and does not explicitly detail specific operational changes or events beyond what is standard for such financial reporting.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding INTENSITY THERAPEUTICS, INC. (INTS).